THORChain co-founder Chad Barraford announced plans to discuss with the protocol's Treasury the possibility of returning some of the developer fund's income earned from fees linked to the Bitget hack. The hack involved $387.5 million stolen from Bitget, with stolen funds laundered through THORChain, generating over $573,000 in liquidity fees. While some accuse THORChain of profiting heavily from stolen funds, Barraford emphasized the developer fund's share is small, around 5%. Node operators can individually choose to return their rewards, but the protocol cannot quickly block malicious swaps due to consensus delays. Barraford also noted past non-adversarial talks with U.S. agencies about THORChain's operations.
The THORChain co-founder and refund discussion on stolen crypto fees provide context for Pluang's market snapshot. As of Oct 07, 2026 04:41 WIB, 9 out of 50 major cryptocurrencies on Pluang rose while 40 fell. EGLD fell 4.07% to Rp79.645, SAND dropped 4.02% to Rp1.184, and ZIL declined 3.81% to Rp63, with typical hold times ranging from 85 to 133 days.
Constellation Brands reported earnings per share of $3.74, surpassing analyst estimates of $3.55, and revenue of $2.63 billion, exceeding the $2.54 billion forecast. The company saw a 5% increase in beer sales and a 17% rise in wine and spirits sales...
Tilray Brands will announce its fiscal Q1 2027 earnings on October 8, with analysts forecasting a loss of $0.16-$0.19 per share on revenues around $265-$268 million, marking about 26% growth from last year. Investors will focus on cannabis and bevera...
On October 6, 2026, five notable stocks surged between 20.9% and 52.7%, driven by various positive developments. Apimeds Pharmaceuticals rose 52.7% after its subsidiary signed a blockchain contract, while Option Care Health gained 32.7% following a $...
On October 6, five notable stocks saw significant declines, with losses ranging from 17.5% to 50.1%. ArriVent BioPharma's shares plunged 46.9% after its lung cancer treatment failed to meet the primary endpoint in a Phase 3 trial. Armada Acquisition ...
Evercore ISI raised its price target for Marvell Technology to $433 from $275, maintaining an Outperform rating. This follows Marvell's optimistic revenue projections, expecting $20 billion by fiscal 2028 and $70-$90 billion by fiscal 2031, driven by...
